Langford DJ, Crager SE, Shehzad Z, Smith SB, Sotocinal SG, Levenstadt JS, Chanda ML, Levitin DJ,
Mogil JS (2006) Social modulation of pain as evidence for empathy in mice. Science
312:1967–1970
Lees P (2009) Analgesic, antiinflammatory, antipyretic drugs. In: Riviere JE, Papich MG (eds)
Veterinary pharmacology and therapeutics, 9th edn. Wiley-Blackwell, Ames, IA, pp 457–492
Lees P, Taylor JBO, Higgins AJ, Sharma SC (1986) Phenylbutazone and oxyphenbutazone
distribution into tissue fluids in the horse. J Vet Pharmacol Ther 9:204–212
Lees P, Taylor JBO, Higgins AJ, Sharma SC (1988) In vitro and in vivo studies on the binding of
phenylbutazone and related drugs to equine feeds and digesta. Res Vet Sci 44:50–56
Lees P, Concordet D, Shojaee Aliabadi F, Toutain PL (2006) Drug selection and optimisation of
dosage schedules to minimize antimicrobial resistance. In: Aarestrup FM (ed) Antimicrobial
resistance in bacteria of animal origin. ASM, Washington, DC, pp 49–71
Lizarraga I, Sumano H, Brumbaugh GW (2004) Pharmacological and pharmacokinetic differences
between donkeys and horses. Equine Vet Educ 16:102–112
Lu C, Li AP (2001) Species comparison in P450 induction: effects of dexamethasone, omeprazole,
and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-
Dawley rat, minipig, and beagle dog. Chem Biol Interact 134:271–281
Maddison J (1999) Owner compliance with drug treatment regimens. J Small Anim Pract
40:348–348
Mahmood I (2005) Interspecies pharmacokinetic scaling allometric principles and applications.
Pine House, Rockeville, Maryland
Maitho TE, Lees P, Taylor JB (1986) Absorption and pharmacokinetics of phenylbutazone in
Welsh Mountain ponies. J Vet Pharmacol Ther 9:26–39
Martinez M, Amidon G, Clarke L, Jones WW, Mitra A, Riviere J (2002) Applying the biophar-
maceutics classification system to veterinary pharmaceutical products. Part II. Physiological
considerations. Adv Drug Deliv Rev 54:825–850
Martinsen B, Horsberg TE (1995) Comparative single-dose pharmacokinetics of four quinolones,
oxolinic acid, flumequine, sarafloxacin, and enrofloxacin, in Atlantic salmon (Salmo salar)
held in seawater at 10C. Antimicrob Agents Chemother 39:1059–1064
Martinsen B, Oppegaard H, Wichstrom R, Myhr E (1992) Temperature-dependent in vitro anti-
microbial activity of four 4-quinolones and oxytetracycline against bacteria pathogenic to fish.
Antimicrob Agents Chemother 36:1738–1743
Mealey KL (2009) Pharmacogenomics. In: Riviere JE, Papich MG (eds) Veterinary pharmacology
and therapeutics, 9th edn. Wiley-Blackwell, Ames, IA
Monshouwer M, van’t Klooster GAE, Nijmeijer SM, Witkamp RF, van Miert ASJPAM (1998)
Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes.
Toxicology in Vitro 12:715–723
Nebbia C, Ceppa L, Dacasto M, Nachtmann C, Carletti M (2001) Oxidative monensin metabolism
and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler
chicks, cattle and rats. J Vet Pharmacol Ther 24:399–403
Norgren A, Ingvast-Larsson C, Kallings P, Fredriksson E, Bondesson U (2000) Contamination and
urinary of flunixin after repeated administration in the horse. In: Williams RB, Houghton E,
Wade JF (eds) 13th International conference of racing analysts and veterinarians. R&W,
Cambridge, UK, pp 377–380
Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S,
Chaudhry MJ, Arshad M, Mahmood S, Ali A, Khan AA (2004) Diclofenac residues as the cause
of vulture population decline in Pakistan. Nature 427:630–633
Paulson SK, Engel L, Reitz B, Bolten S, Burton EG, Maziasz TJ, Yan B, Schoenhard GL (1999)
Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor,
celecoxib. Drug Metab Dispos 27:1133–1142
Pilar G, Nunez R, Mclennan IS et al (1987) Muscarinic and nicotinic synaptic activation of the
developing chicken iris. J Neurosci 7:3813–3826
Species Differences in Pharmacokinetics and Pharmacodynamics 47